KYMR
SELLKymera Therapeutics, Inc.· Healthcare
Market Cap: $9.4B
Score
23
23
ANDAMENTO PREZZO
$112.63+274.56%
Prezzi aggiornati al 21 ott 2026
INDICATORI TECNICI
RSI (14 giorni)
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)
MACD (12,26,9)
↑ RialzistaMACD -1.224 · Signal -1.719 · Hist 0.495
Prezzo vs Medie Mobili
SMA 20
$109.91-60.5%
SMA 50
$115.15-62.3%
SMA 200
$94.90-54.3%
Bollinger Band %B0% — Vicino lower band
$104mid $110$116
Volume ratio (vs media 20gg)1.22x
BREAKDOWN SCORE (0 → 100)
P/E Trailing0.0 / 25
FCF Yield0.0 / 25
Price/Book8.2 / 15
EPS0.0 / 15
Debt/Equity10.0 / 10
Dividendo0.0 / 5
Momentum 90gg5.0 / 5
FONDAMENTALI
Clicca i per spiegazione✓ 2 ok~ attenzione✗ 4 negativi
P/E Trailing
—
✗P/E Forward
N/A (perdita)
✗P/B
6.2x
✗FCF Yield
-2.5%
✗EPS TTM
-3,25
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
466.4%
✓Debt/Equity
0.1x
Market Cap
$9.4B
Div. Yield
0.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare
Aggiornato: 22 ott 2026